Morning or Pre-Shot Meal Your pre-shot meal should be small, familiar, and protein-first
It took more than two years of intensive, capital-intensive manufacturing expansion for both companies to resolve those shortages: tirzepatide was removed from the FDA shortage list on December 19, 2024, semaglutide on February 21, 2025
These may include financial losses, such as medical expenses and lost income, or personal losses, such as pain and suffering or diminished quality of life
Experts note that although they are seeing a sharp rise in exposures, the severity of cases and poisonings has not changed over time and are not worse compared to past GLP-1 exposures
Common GLP-1 side effects may include nausea, diarrhea, vomiting, constipation, stomach pain, headache, fatigue, indigestion, dizziness, bloating, belching, gas, reflux, and low blood sugar, especially in people with type 2 diabetes taking insulin or sulfonylureas